Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt 2.04
EW's Cash to Debt is ranked lower than
53% of the 315 Companies
in the Global Medical Devices industry.

( Industry Median: 2.75 vs. EW: 2.04 )
Ranked among companies with meaningful Cash to Debt only.
EW' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.90 Max: N/A
Current: 2.04
Equity to Asset 0.62
EW's Equity to Asset is ranked lower than
53% of the 293 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. EW: 0.62 )
Ranked among companies with meaningful Equity to Asset only.
EW' s Equity to Asset Range Over the Past 10 Years
Min: 0.37  Med: 0.59 Max: 0.74
Current: 0.62
0.37
0.74
Interest Coverage 49.53
EW's Interest Coverage is ranked lower than
62% of the 170 Companies
in the Global Medical Devices industry.

( Industry Median: 261.39 vs. EW: 49.53 )
Ranked among companies with meaningful Interest Coverage only.
EW' s Interest Coverage Range Over the Past 10 Years
Min: 14.15  Med: 63.10 Max: 118.46
Current: 49.53
14.15
118.46
F-Score: 5
Z-Score: 9.75
M-Score: -2.17
WACC vs ROIC
6.08%
32.05%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 25.62
EW's Operating margin (%) is ranked higher than
95% of the 301 Companies
in the Global Medical Devices industry.

( Industry Median: 2.36 vs. EW: 25.62 )
Ranked among companies with meaningful Operating margin (%) only.
EW' s Operating margin (%) Range Over the Past 10 Years
Min: 13.99  Med: 18.77 Max: 53.09
Current: 25.62
13.99
53.09
Net-margin (%) 19.85
EW's Net-margin (%) is ranked higher than
89% of the 301 Companies
in the Global Medical Devices industry.

( Industry Median: 1.62 vs. EW: 19.85 )
Ranked among companies with meaningful Net-margin (%) only.
EW' s Net-margin (%) Range Over the Past 10 Years
Min: 7.92  Med: 14.59 Max: 34.92
Current: 19.85
7.92
34.92
ROE (%) 21.30
EW's ROE (%) is ranked higher than
90% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 2.51 vs. EW: 21.30 )
Ranked among companies with meaningful ROE (%) only.
EW' s ROE (%) Range Over the Past 10 Years
Min: 11.99  Med: 18.01 Max: 43.42
Current: 21.3
11.99
43.42
ROA (%) 13.33
EW's ROA (%) is ranked higher than
90% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 0.42 vs. EW: 13.33 )
Ranked among companies with meaningful ROA (%) only.
EW' s ROA (%) Range Over the Past 10 Years
Min: 6.75  Med: 12.76 Max: 26.02
Current: 13.33
6.75
26.02
ROC (Joel Greenblatt) (%) 73.39
EW's ROC (Joel Greenblatt) (%) is ranked higher than
92% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 3.95 vs. EW: 73.39 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
EW' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 38.61  Med: 50.48 Max: 134.3
Current: 73.39
38.61
134.3
Revenue Growth (3Y)(%) 15.00
EW's Revenue Growth (3Y)(%) is ranked higher than
85% of the 208 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. EW: 15.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
EW' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 10.60 Max: 15
Current: 15
0
15
EBITDA Growth (3Y)(%) 57.90
EW's EBITDA Growth (3Y)(%) is ranked higher than
96% of the 182 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. EW: 57.90 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
EW' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 16.05 Max: 57.9
Current: 57.9
0
57.9
EPS Growth (3Y)(%) 55.70
EW's EPS Growth (3Y)(%) is ranked higher than
90% of the 186 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. EW: 55.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
EW' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 20.95 Max: 300.9
Current: 55.7
0
300.9
» EW's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

EW Guru Trades in Q1 2015

Lee Ainslie 1,960 sh (New)
Steven Cohen 239,400 sh (New)
Paul Tudor Jones 106,095 sh (+1612.31%)
Jim Simons 668,400 sh (+37.96%)
Jeremy Grantham 134,069 sh (+5.18%)
PRIMECAP Management 280,000 sh (unchged)
Vanguard Health Care Fund 3,402,670 sh (unchged)
Ron Baron 570,988 sh (-1.01%)
RS Investment Management 59,621 sh (-2.00%)
Joel Greenblatt 241,467 sh (-2.59%)
Pioneer Investments 162,473 sh (-7.52%)
» More
Q2 2015

EW Guru Trades in Q2 2015

John Hussman 25,000 sh (New)
Ray Dalio 31,948 sh (New)
Pioneer Investments 201,818 sh (+24.22%)
RS Investment Management 69,285 sh (+16.21%)
RS Investment Management 69,285 sh (+16.21%)
Vanguard Health Care Fund 3,402,670 sh (unchged)
PRIMECAP Management 280,000 sh (unchged)
Lee Ainslie 1,960 sh (unchged)
Jeremy Grantham 127,069 sh (-5.22%)
Steven Cohen 173,200 sh (-27.65%)
Ron Baron 379,466 sh (-33.54%)
Joel Greenblatt 110,914 sh (-54.07%)
Jim Simons 290,200 sh (-56.58%)
Paul Tudor Jones 3,800 sh (-96.42%)
» More
Q3 2015

EW Guru Trades in Q3 2015

Louis Moore Bacon 101,319 sh (New)
Frank Sands 1,325,385 sh (New)
RS Investment Management 94,785 sh (+36.80%)
Steven Cohen 233,200 sh (+34.64%)
Jim Simons 361,312 sh (+24.50%)
Paul Tudor Jones 4,529 sh (+19.18%)
Pioneer Investments 202,586 sh (+0.38%)
PRIMECAP Management 280,000 sh (unchged)
John Hussman 25,000 sh (unchged)
Steven Cohen 150,000 sh (unchged)
Lee Ainslie Sold Out
Ray Dalio Sold Out
Jeremy Grantham 124,620 sh (-1.93%)
Ron Baron 353,627 sh (-6.81%)
Vanguard Health Care Fund 2,352,060 sh (-30.88%)
Joel Greenblatt 7,777 sh (-92.99%)
» More
Q4 2015

EW Guru Trades in Q4 2015

John Hussman 50,000 sh (+100.00%)
Vanguard Health Care Fund 3,217,520 sh (+36.80%)
» More
» Details

Insider Trades

Latest Guru Trades with EW

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Edwards Lifesciences Corp

Weekly 52-Week Highs Highlight: H&R Block, Edwards Lifesciences, Amazon.com, Chubb A summary of companies whose stocks have recently reached their yearly highs
According to GuruFocus list of 52-week highs, H&R Block Inc., Edwards Lifesciences Corp., Amazon.com Inc. and Chubb Corp. have all reached their 52-week highs. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 39.00
EW's P/E(ttm) is ranked lower than
67% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 30.18 vs. EW: 39.00 )
Ranked among companies with meaningful P/E(ttm) only.
EW' s P/E(ttm) Range Over the Past 10 Years
Min: 11.18  Med: 27.96 Max: 50.48
Current: 39
11.18
50.48
Forward P/E 28.01
EW's Forward P/E is ranked lower than
80% of the 181 Companies
in the Global Medical Devices industry.

( Industry Median: 17.92 vs. EW: 28.01 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 38.90
EW's PE(NRI) is ranked lower than
67% of the 196 Companies
in the Global Medical Devices industry.

( Industry Median: 28.80 vs. EW: 38.90 )
Ranked among companies with meaningful PE(NRI) only.
EW' s PE(NRI) Range Over the Past 10 Years
Min: 11.16  Med: 28.32 Max: 49.62
Current: 38.9
11.16
49.62
P/B 7.07
EW's P/B is ranked lower than
99.99% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 2.58 vs. EW: 7.07 )
Ranked among companies with meaningful P/B only.
EW' s P/B Range Over the Past 10 Years
Min: 2.9  Med: 4.82 Max: 8.46
Current: 7.07
2.9
8.46
P/S 7.39
EW's P/S is ranked lower than
97% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 2.33 vs. EW: 7.39 )
Ranked among companies with meaningful P/S only.
EW' s P/S Range Over the Past 10 Years
Min: 2.31  Med: 3.99 Max: 7.44
Current: 7.39
2.31
7.44
PFCF 42.06
EW's PFCF is ranked lower than
64% of the 199 Companies
in the Global Medical Devices industry.

( Industry Median: 33.16 vs. EW: 42.06 )
Ranked among companies with meaningful PFCF only.
EW' s PFCF Range Over the Past 10 Years
Min: 7.8  Med: 28.95 Max: 534.33
Current: 42.06
7.8
534.33
POCF 33.61
EW's POCF is ranked lower than
74% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 21.39 vs. EW: 33.61 )
Ranked among companies with meaningful POCF only.
EW' s POCF Range Over the Past 10 Years
Min: 7.32  Med: 19.55 Max: 49.08
Current: 33.61
7.32
49.08
EV-to-EBIT 28.29
EW's EV-to-EBIT is ranked lower than
63% of the 267 Companies
in the Global Medical Devices industry.

( Industry Median: 22.96 vs. EW: 28.29 )
Ranked among companies with meaningful EV-to-EBIT only.
EW' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.8  Med: 20.20 Max: 39.7
Current: 28.29
6.8
39.7
EV-to-EBITDA 25.36
EW's EV-to-EBITDA is ranked lower than
70% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 16.67 vs. EW: 25.36 )
Ranked among companies with meaningful EV-to-EBITDA only.
EW' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.4  Med: 15.00 Max: 33.5
Current: 25.36
6.4
33.5
PEG 1.39
EW's PEG is ranked higher than
79% of the 70 Companies
in the Global Medical Devices industry.

( Industry Median: 3.27 vs. EW: 1.39 )
Ranked among companies with meaningful PEG only.
EW' s PEG Range Over the Past 10 Years
Min: 0.45  Med: 1.34 Max: 3.43
Current: 1.39
0.45
3.43
Shiller P/E 60.93
EW's Shiller P/E is ranked lower than
77% of the 69 Companies
in the Global Medical Devices industry.

( Industry Median: 33.18 vs. EW: 60.93 )
Ranked among companies with meaningful Shiller P/E only.
EW' s Shiller P/E Range Over the Past 10 Years
Min: 34.67  Med: 60.76 Max: 118.59
Current: 60.93
34.67
118.59
Current Ratio 4.03
EW's Current Ratio is ranked higher than
68% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 2.82 vs. EW: 4.03 )
Ranked among companies with meaningful Current Ratio only.
EW' s Current Ratio Range Over the Past 10 Years
Min: 0.89  Med: 2.60 Max: 5.56
Current: 4.03
0.89
5.56
Quick Ratio 3.40
EW's Quick Ratio is ranked higher than
70% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 2.04 vs. EW: 3.40 )
Ranked among companies with meaningful Quick Ratio only.
EW' s Quick Ratio Range Over the Past 10 Years
Min: 0.49  Med: 1.98 Max: 4.83
Current: 3.4
0.49
4.83
Days Inventory 187.11
EW's Days Inventory is ranked lower than
66% of the 280 Companies
in the Global Medical Devices industry.

( Industry Median: 136.13 vs. EW: 187.11 )
Ranked among companies with meaningful Days Inventory only.
EW' s Days Inventory Range Over the Past 10 Years
Min: 126.28  Med: 155.22 Max: 208.39
Current: 187.11
126.28
208.39
Days Sales Outstanding 50.37
EW's Days Sales Outstanding is ranked higher than
77% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 69.24 vs. EW: 50.37 )
Ranked among companies with meaningful Days Sales Outstanding only.
EW' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.74  Med: 54.46 Max: 69.95
Current: 50.37
38.74
69.95
Days Payable 42.28
EW's Days Payable is ranked lower than
65% of the 255 Companies
in the Global Medical Devices industry.

( Industry Median: 60.71 vs. EW: 42.28 )
Ranked among companies with meaningful Days Payable only.
EW' s Days Payable Range Over the Past 10 Years
Min: 33.96  Med: 55.71 Max: 189.22
Current: 42.28
33.96
189.22

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 25.64
EW's Price/Net Current Asset Value is ranked lower than
86% of the 293 Companies
in the Global Medical Devices industry.

( Industry Median: 6.17 vs. EW: 25.64 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
EW' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 10.47  Med: 16.23 Max: 568
Current: 25.64
10.47
568
Price/Tangible Book 10.60
EW's Price/Tangible Book is ranked lower than
80% of the 378 Companies
in the Global Medical Devices industry.

( Industry Median: 4.30 vs. EW: 10.60 )
Ranked among companies with meaningful Price/Tangible Book only.
EW' s Price/Tangible Book Range Over the Past 10 Years
Min: 5.58  Med: 9.12 Max: 219.67
Current: 10.6
5.58
219.67
Price/Projected FCF 2.31
EW's Price/Projected FCF is ranked lower than
62% of the 212 Companies
in the Global Medical Devices industry.

( Industry Median: 1.93 vs. EW: 2.31 )
Ranked among companies with meaningful Price/Projected FCF only.
EW' s Price/Projected FCF Range Over the Past 10 Years
Min: 1.35  Med: 1.89 Max: 3.62
Current: 2.31
1.35
3.62
Price/DCF (Earnings Based) 1.28
EW's Price/DCF (Earnings Based) is ranked higher than
72% of the 43 Companies
in the Global Medical Devices industry.

( Industry Median: 1.81 vs. EW: 1.28 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.86
EW's Price/Median PS Value is ranked lower than
87% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 1.00 vs. EW: 1.86 )
Ranked among companies with meaningful Price/Median PS Value only.
EW' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.31  Med: 0.73 Max: 1.75
Current: 1.86
0.31
1.75
Price/Peter Lynch Fair Value 1.56
EW's Price/Peter Lynch Fair Value is ranked higher than
82% of the 68 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. EW: 1.56 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
EW' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.59  Med: 1.39 Max: 3.25
Current: 1.56
0.59
3.25
Price/Graham Number 4.37
EW's Price/Graham Number is ranked lower than
76% of the 229 Companies
in the Global Medical Devices industry.

( Industry Median: 3.38 vs. EW: 4.37 )
Ranked among companies with meaningful Price/Graham Number only.
EW' s Price/Graham Number Range Over the Past 10 Years
Min: 1.61  Med: 3.31 Max: 29.59
Current: 4.37
1.61
29.59
Earnings Yield (Greenblatt) (%) 3.50
EW's Earnings Yield (Greenblatt) (%) is ranked higher than
66% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. EW: 3.50 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
EW' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.5  Med: 5.00 Max: 14.7
Current: 3.5
2.5
14.7
Forward Rate of Return (Yacktman) (%) 35.31
EW's Forward Rate of Return (Yacktman) (%) is ranked higher than
95% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 5.80 vs. EW: 35.31 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
EW' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 6.4  Med: 20.75 Max: 37.6
Current: 35.31
6.4
37.6

More Statistics

Revenue(Mil) $2494
EPS $ 2.25
Beta0.58
Short Percentage of Float1.52%
52-Week Range $61.38 - 84.84
Shares Outstanding(Mil)215.71

Analyst Estimate

Dec16 Dec17 Dec18
Revenue(Mil) 2,673 2,963 3,190
EPS($) 2.41 2.82 3.04
EPS without NRI($) 2.41 2.82 3.04

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:EWL.Germany,
Edwards Lifesciences Corp was incorporated in Delaware on September 10, 1999. The Company is the manufacturer of heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. It is also a global leader in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. It conducts operations worldwide and are managed in the following geographical regions: United States, Europe, Japan and Rest of World. The products and technologies provided by the Company to treat advanced cardiovascular disease or critically ill patients are categorized into the following main areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. The Company's Surgical Heart Valve Therapy portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Company's Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. In the Critical Care portfolio, Edwards Lifesciences' products include pulmonary artery catheters, disposable pressure transducers and advanced monitoring systems. The portfolio also includes a line of balloon catheter-based vascular products, surgical clips and inserts. The Company competes with many companies, including divisions of companies much larger than it and smaller companies that compete in specific product lines or certain geographies. The Company's Surgical Heart Valve Therapy and Transcatheter Heart Valve products are manufactured in California and Utah in the United States, Switzerland, and Singapore. Critical Care products are manufactured primarily in its facilities located in Puerto Rico and the Dominican Republic. The Company's products and technologies are subject to regulation by numerous domestic and foreign government agencies, including the FDA, and various laws and regulations governing the development, testing, manufacturing, labeling, marketing and distribution of its products and technologies.
» More Articles for EW

Headlines

Articles On GuruFocus.com
Weekly 52-Week Highs Highlight: H&R Block, Edwards Lifesciences, Amazon.com, Chubb Nov 02 2015 
The Best Companies of the Medical Industry – September 2015 Sep 25 2015 
The Problem with Mechanical Investment Strategies and How You Can Find Your Own Ideas May 27 2015 
Vanguard Health Care Fund's Undervalued Stocks Apr 03 2015 
Fairly Valued Long-Term Performer – Edwards Lifesciences Mar 23 2015 
Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
Edwards Lifesciences Invests $50 Million in New Heart Failure Technology Dec 10 2014 
EW: Potential for Capital Appreciation Oct 03 2014 
Outperform with Historical Low P/B Portfolios Sep 12 2014 
Weekly 52-Week Highs Highlight: HNP, HDB, MMC, EW Aug 31 2014 

More From Other Websites
Top Funds Heart Edwards Lifesciences, Bump Lilly Feb 05 2016
Is Edwards Lifesciences an Incredible Momentum Stock? 3 Reasons Why EW Will Be Tough to Beat Feb 05 2016
Cramer Remix: How to conquer rotations Feb 04 2016
Edwards Lifesciences Announces $325 Million Accelerated Share Repurchase Feb 04 2016
Mattel’s Stock Not Playing Around Anymore Feb 04 2016
Edwards Lifesciences Corp. Earnings Analysis: 2015 By the Numbers Feb 04 2016
Edwards Lifesciences (EW) Worth Watching: Stock Up 8.3% Feb 04 2016
Edwards Lifesciences Pops On Strong Q4, 2016 Forecast Feb 03 2016
Edwards LifeSciences (EW) Stock Advances on Earnings Beat, Raised Guidance Feb 03 2016
Edwards Lifesciences Beats Q4 Earnings, Raises '16 View Feb 03 2016
Edwards Lifesciences To Present At The Leerink Global Healthcare Conference Feb 03 2016
Morning Movers: Alexion, Merck Drop on Earnings; Atwood Oceanics Gains Feb 03 2016
Edited Transcript of EW earnings conference call or presentation 2-Feb-16 10:00pm GMT Feb 03 2016
Yahoo Leads 5 Stocks Moving Late On Earnings Reports Feb 02 2016
3 Stocks Moving Big In Tuesday's After-Hours Session Feb 02 2016
[$$] Edwards Lifesciences Revenue Rises 8.6%, 2016 Outlook Raised Feb 02 2016
Edwards Lifesciences tops Street 4Q forecasts Feb 02 2016
Edwards Lifesciences tops Street 4Q forecasts Feb 02 2016
Edwards Lifesciences boosts full-year profit outlook Feb 02 2016
EDWARDS LIFESCIENCES CORP Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 02 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK